Glenmark Pharmaceuticals gains 7% on strong June quarter performance
Click here to read full article from source
Mumbai, Aug. 17 -- Glenmark Pharmaceuticals jumped as much as 6.96% on Monday after the company's consolidated net profit more than doubled to Rs.254.04 crore in Q1 June 2020 from Rs.109.28 crore in Q1 June 2019.
At 12:56 pm, Glenmark Pharmaceuticals was trading at Rs.486 up 2.23% from its previous close, while the benchmark index, Sensex gained 0.16% to 37,937.56.
The company's consolidated revenue increased by 0.94% to Rs.2,344.78 crore in the June quarter from Rs.2,322.87 crore in the same quarter of last fiscal. Earnings before interest tax depreciation and ammortisation (EBITDA) stood at Rs.478.06 crore in the quarter ended 30 June 2020 as against Rs.341.91 crore in the previous corresponding quarter, registering an increase of 39....
To read the full article or to get the complete feed from this publication, please Contact Us